These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31797416)

  • 1. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.
    Lee S; Seow CH; Adhikari K; Metcalfe A
    Aliment Pharmacol Ther; 2020 Mar; 51(5):544-552. PubMed ID: 31797416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to and Persistence with Antidepressant Medication during Pregnancy: Does It Differ by the Class of Antidepressant Medication Prescribed?
    Adhikari K; Patten SB; Lee S; Metcalfe A
    Can J Psychiatry; 2019 Mar; 64(3):199-208. PubMed ID: 30252505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing in pregnant women with inflammatory bowel disease and its relationship to congenital malformations in Japan.
    Takahashi S; Kakuta Y; Obara T; Ishikawa T; Nagai H; Shimoyama Y; Naito T; Moroi R; Shiga H; Mano N; Kinouchi Y; Masamune A
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1291-1298. PubMed ID: 38538533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and Attitudes Towards Medication Adherence during Pregnancy in Inflammatory Bowel Disease.
    Gallinger ZR; Rumman A; Nguyen GC
    J Crohns Colitis; 2016 Aug; 10(8):892-7. PubMed ID: 26896087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.
    Selinger CP; Eaden J; Jones DB; Katelaris P; Chapman G; McDonald C; Smith P; Lal S; Leong RW; McLaughlin J; Robinson A
    Inflamm Bowel Dis; 2013 Sep; 19(10):2199-206. PubMed ID: 23899547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.
    Mozaffari S; Abdolghaffari AH; Nikfar S; Abdollahi M
    Hum Exp Toxicol; 2015 May; 34(5):445-59. PubMed ID: 25378092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
    Watanabe C; Nagahori M; Fujii T; Yokoyama K; Yoshimura N; Kobayashi T; Yamagami H; Kitamura K; Takashi K; Nakamura S; Naganuma M; Ishihara S; Esaki M; Yonezawa M; Kunisaki R; Sakuraba A; Kuji N; Miura S; Hibi T; Suzuki Y; Hokari R
    Dig Dis Sci; 2021 Feb; 66(2):577-586. PubMed ID: 32249373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
    Lee S; Seow CH; Nerenberg K; Bertazzon S; Leung Y; Huang V; Whitten T; Coward S; Panaccione R; Kaplan GG; Metcalfe A
    Inflamm Bowel Dis; 2024 Jul; 30(7):1071-1079. PubMed ID: 37499061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing medication adherence in inflammatory bowel diseases. A comparison between a self-administered scale and a pharmacy refill index.
    de Castro ML; Sanromán L; Martín A; Figueira M; Martínez N; Hernández V; Del Campo V; Pineda JR; Martínez-Cadilla J; Pereira S; Rodríguez Prada JI
    Rev Esp Enferm Dig; 2017 Aug; 109(8):542-551. PubMed ID: 28679280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases.
    Govani SM; Noureldin M; Higgins PDR; Heisler M; Saini SD; Stidham RW; Waljee JF; Waljee AK
    Am J Gastroenterol; 2018 Feb; 113(2):276-282. PubMed ID: 29231192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
    Campos S; Portela F; Sousa P; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease.
    Leung YP; Kaplan GG; Coward S; Tanyingoh D; Kaplan BJ; Johnston DW; Barkema HW; Ghosh S; Panaccione R; Seow CH; ;
    J Crohns Colitis; 2015 Mar; 9(3):223-30. PubMed ID: 25576754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse.
    Robinson A; Hankins M; Wiseman G; Jones M
    Aliment Pharmacol Ther; 2013 Sep; 38(5):531-8. PubMed ID: 23834298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and IBD treatment: this challenging interplay from a patients' perspective.
    Mountifield RE; Prosser R; Bampton P; Muller K; Andrews JM
    J Crohns Colitis; 2010 Jun; 4(2):176-82. PubMed ID: 21122502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
    Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
    J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Frequency of Clinic Visits Was Not Associated with Medication Adherence or Outcome in Children with Inflammatory Bowel Diseases.
    Kluthe C; Tsui J; Spady D; Carroll M; Wine E; Huynh HQ
    Can J Gastroenterol Hepatol; 2018; 2018():4687041. PubMed ID: 29682493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of an Integrated Model of Care on Outcomes of Patients With Inflammatory Bowel Diseases: Evidence From a Population-Based Study.
    Peña-Sánchez JN; Lix LM; Teare GF; Li W; Fowler SA; Jones JL
    J Crohns Colitis; 2017 Dec; 11(12):1471-1479. PubMed ID: 28981633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of TNF-α inhibitors during IBD pregnancy: a systematic review.
    Nielsen OH; Loftus EV; Jess T
    BMC Med; 2013 Jul; 11():174. PubMed ID: 23902720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.